Wednesday, December 08, 2004


A Matter Of Great Import

Collin Levey highlights a contrast in Bill Clinton: his opposition to copyright infringement of his book vs his support of copyright infringement where drug companies are involved. Worth a read.

This brings up another question: if the drug companies are consistently overcharging, why haven't they been replaced? Most of academia is liberal, as are no end of governments worldwide. They have the resources to duplicate the work of the drug companies, and on an equivalent scale, so why haven't they already done so?

If their own arguments against the drug companies are true, then those who oppose the companies' copyright protections are just as callous as the companies themselves ever could be.

I said if.

Hat Tip: